TARO - TARO PHARMACEUTICAL INDUSTRIES LTD


42.97
0   0%

Share volume: 14,845
Last Updated: 06-21-2024

PREVIOUS CLOSE
CHG
CHG%

$42.97
0.00
0.00%
This ticker is disabled and data are no longer maintained and up to date.
Company vs Stock growth
vs
Performance
5 Days
0.56%
1 Month
0.51%
3 Months
2.09%
6 Months
1.56%
1 Year
10.83%
2 Year
13.08%
Key data
Stock price
$42.97
P/E Ratio 
0.00
DAY RANGE
$42.89 - $42.97
EPS 
$0.00
52 WEEK RANGE
$32.67 - $45.76
52 WEEK CHANGE
$0.11
MARKET CAP 
1.615 B
YIELD 
N/A
SHARES OUTSTANDING 
37.585 M
DIVIDEND
$12.81
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
BETA 
0.44
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$173,610
AVERAGE 30 VOLUME 
$63,187
Company detail
CEO: Uday V. Baldota
Region: US
Website: taro.com
Employees: 1,460
IPO year: 1993
Issue type: Common Stock
Market: NYSE
Industry:
Sector:

Taro Pharmaceutical Industries Ltd. develops, manufactures, and markets prescription and over-the-counter pharmaceutical products in the United States, Canada, Israel, and internationally. The company also develops and manufactures active pharmaceutical ingredients primarily for use in its finished dosage form products. It distributes and sells its products directly to wholesalers, retail drug store chains, food chains, hospitals, mass merchandisers, grocery chains, and other direct purchasers and customers.

Recent news